New insights on the effects of blend composition on the biodegradation and permeability of Inulin-Eudragit RS film coatings for colon drug delivery

Abstract

Inulin has been applied in InulinEudragit RS (Inu-ERS) coatings as the component responsible for degradation by human microbiota. However, studies on how bacterial enzymes can degrade polysaccharides like inulin imbedded in water insoluble polymers like Eudragit RS are still elusive. The present work aims at elucidating the complex process of enzyme triggered biodegradation of inulin with various molecular weights in isolated films with Eudragit RS. The ratio of inulin to Eudragit RS was varied to create films with different degree of hydrophilicity. The phase behavior study revealed that blends of inulin and Eudragit RS are phase separated systems. The film permeability was studied by determination of the permeability coefficient of caffeine and the fraction of inulin that was released from the films in a buffer solution with or without inulinase was quantified. Together with the morphology characterization of the Inu-ERS films with and without incubation in the enzyme solution, these results suggest that the action of the enzyme was only limited to the fraction of inulin released in the buffer solution. Inulin fully embedded in the Eudragit RS matrix was not degraded. The permeation of the model drug caffeine occurred in the phase-separated film as a result of pores formed as a consequence of inulin release. The inulin to Eudragit RS blend ratio and the molecular weight of inulin affected the percolation threshold, the release of inulin, the morphology of the film formed thereafter and the connectivity of the formed water channels, thus influencing the drug permeation properties.

Introduction

The application of a colon-specific delivery system for drugs utilized to treat inflammatory bowel diseases, comprising ulcerative colitis and Crohn’s disease, can prevent the untimely release in the upper gastrointestinal tract, thereby avoiding systemic side effects and providing the desired colon-specific therapeutic efficiency[1], [2]. Based on the specific physiological conditions of the gastrointestinal tract, such as the pH gradient, different transit times required to reach specific sites, and the distribution of various microorganisms, oral therapeutic drugs surrounded by colonic physiological condition-responsive coatings can realize the purpose of colon targeting[3], [4], [5]. A coating system susceptible to degradation by colonic microbiota is a practically promising approach[6], [7]. Numerous polysaccharides and oligosaccharides have been used in the development of colonic microbiota-dependent systems[8].

Inulin and Eudragit RS (ERS) are coating constituent materials that allow to be used in biodegradable colonic drug delivery systems. Inu-ERS coating is a colon-targeted drug delivery strategy triggered by colonic microbial enzymes. The coating component inulin is indigestible by the upper digestive tract[9]. It can be enzymatically degraded by enzymes produced by the human colonic microbiome, which cleaves the β-(2,1)-glycosidic bonds between the fructosyl units, thus destroying the structure of inulin[10]. Based on the degree of polymerization (DP), inulin can be subdivided into oligosaccharide (DP: 2 to 9) or polysaccharide (DP: 10 to 60). ERS is a copolymer of methyl methacrylate, ethyl acrylate and a low content of trimethyl amino ethyl methacrylate chloride. Complementary properties would allow this combination to have sufficiently low drug penetration in the stomach and small intestine for ensuring drug release in the colon as a consequence of specific enzymatic degradability of inulin. This leads to the formation of pores, which facilitates the subsequent release of drugs in the colon. The hydrophobicity of ERS compensates for the poor mechanical properties and high water solubility of polysaccharides[11].

Up until now, considerable research has focused on the development and optimization of microbially triggered colon-specific coatings for drug reservoirs[6], [12], [13], [14]. In spite of the fact that most of the studies concern the permeation properties, mechanical properties of the coated membranes and the efficiency of in vitro and in vivo drug release from the reservoir, only a few studies discuss that drug release across coated membranes is the result of a combined effect of water imbibition and microbial enzymatic degradation[5], [15], [16], [17], [18]. To the best of our knowledge, studies on how enzymes degrade polysaccharides in coated films after exposure to water are lacking so far. The proportion, type, distribution and preparation process of water-soluble polysaccharides and water-insoluble polymers may all be factors that affect the way and extent of enzyme-triggered degradation of polysaccharides in blend films, which in turn affects the drug diffusion rate and drug diffusion mechanism.

The susceptibility of inulin to enzymes adds a consideration to the transport of drugs through blend films, as the extent to which enzymes degrade different molecular weights or different amounts of inulin within the film will also vary. Leakage of inulin is important for drug release from pellet coatings[19]. In the current work, we prepared inulin-ERS composite films by dispersion casting. Isolated films are convenient model systems for studying release properties of film coated pellets, as they facilitate the measurement of permeability using a diffusion device and are adequate as an initial screening method[20].

The purpose of this paper is to study the complex effects of polysaccharide biodegradation in films with various molecular weights and ratios of inulin and ERS on film permeability, hence to understand how the enzyme degrades the polysaccharide within the film and to investigate the effect of component structure on biodegradation, and permeability characteristics of the film.

Read more here

Materials

Inulin from chicory with a low degree of polymerization (InuLP with an average DP of 5) and with a high degree of polymerization (InuHP with an average DP of 23) were received from Orafti (Tienen, Belgium). Eudragit® RS 30D (ERS, a polymethacrylate aqueous dispersion) was provided by Evonik Röhm GmbH (Darmstadt, Germany), triethyl citrate (TEC) was purchased from ThermoFisher GmbH (Kandel, Germany), and caffeine (Ph. Eur.) supplied by Sigma Aldrich (Darmstadt, Germany)

Jiabi Ouyang, Sien Dedroog, Guy Van den Mooter, New insights on the effects of blend composition on the biodegradation and permeability of Inulin-Eudragit RS film coatings for colon drug delivery, European Journal of Pharmaceutics and Biopharmaceutics, 2023, ISSN 0939-6411, https://doi.org/10.1016/j.ejpb.2023.05.021.


Visit our new Webinar:

Solving capping challenges using mannitol as an excipient model

Get more information & register here:

Solving capping challenges using mannitol as an excipient model
Solving capping challenges using mannitol as an excipient model
You might also like